heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with loratadine in 1 studies
| Studies (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Trials (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Recent Studies (post-2010) (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Studies (loratadine) | Trials (loratadine) | Recent Studies (post-2010) (loratadine) |
|---|---|---|---|---|---|
| 148 | 0 | 45 | 1,317 | 462 | 339 |
| Protein | Taxonomy | heptakis(2,6-o-dimethyl)beta-cyclodextrin (IC50) | loratadine (IC50) |
|---|---|---|---|
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.016 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.23 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.245 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1717 | |
| Bile acid receptor | Homo sapiens (human) | 3.07 | |
| Sodium-dependent neutral amino acid transporter B(0)AT2 | Homo sapiens (human) | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aigner, Z; Balogh, Á; Blazsó, G; Mándity, I; Martinek, T; Sipos, P; Szabados-Nacsa, A; Szabó-Révész, P | 1 |
1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and loratadine
| Article | Year |
|---|---|
Physico-chemical characterization and in vitro/in vivo evaluation of loratadine:dimethyl-β-cyclodextrin inclusion complexes.
Topics: Animals; beta-Cyclodextrins; Biological Availability; Chromatography, High Pressure Liquid; Histamine H1 Antagonists, Non-Sedating; Hydrogen-Ion Concentration; In Vitro Techniques; Loratadine; Male; Rats; Rats, Wistar; Solubility; Spectrometry, Mass, Electrospray Ionization | 2011 |